ACTG Publications

Parsimonious covariate selection with censored outcomes.DiRienzo, Albert Gregory2016 06Biometrics272
Partner-Focused Adherence Intervention for Second-line Antiretroviral Therapy: A Multinational Randomized Trial (ACTG A5234).Gross, Robert ; Zheng, Lu ; La Rosa, Alberto ; Sun, Xin ; Rosenkranz, Susan L ; Cardoso, Sandra Wagner ; Ssali, Francis ; Camp, Rob ; Godfrey, Catherine ; Cohn, Susan E ; Robbins, Gregory K ; Chisada, Anthony ; Wallis, Carole L ; Reynolds, Nancy R ; Lu, Darlene ; Safren, Steven A ; Hosey, Lara ; Severe, Patrice ; Collier, Ann C2015 Jan 1Lancet HIV12
Partners in Crime: The Role of CMV in Immune Dysregulation and Clinical Outcome During HIV Infection.Freeman, Michael L ; Lederman, Michael M ; Gianella, Sara2016 FebCurr HIV/AIDS Rep113
Patterns of antiretroviral therapy adherence and impact on HIV RNA among patients in North America.Genberg, Becky L ; Wilson, Ira B ; Bangsberg, David R ; Arnsten, Julia ; Goggin, Kathy ; Remien, Robert H ; Simoni, Jane ; Gross, Robert ; Reynolds, Nancy ; Rosen, Marc ; Liu, Honghu ; MACH14 Investigators2012 Jul 17AIDS1126
Patterns of peripheral neuropathy in ART-naïve patients initiating modern ART regimen.Lee, Anthony J ; Bosch, Ronald J ; Evans, Scott R ; Wu, Kunling ; Harrison, Taylor ; Grant, Philip ; Clifford, David B2015 AprJ Neurovirol221
Performance characteristics of the Cavidi ExaVir viral load assay and the ultra-sensitive P24 assay relative to the Roche Monitor HIV-1 RNA assay.Stewart, Paul ; Cachafeiro, Ada ; Napravnik, Sonia ; Eron, Joseph J ; Frank, Ian ; van der Horst, Charles ; Bosch, Ronald J ; Bettendorf, Daniel ; Bohlin, Peter ; Fiscus, Susan A2010 NovJ Clin Virol349
Peripheral and central fat changes in subjects randomized to abacavir-lamivudine or tenofovir-emtricitabine with atazanavir-ritonavir or efavirenz: ACTG Study A5224s.McComsey, Grace A ; Kitch, Douglas ; Sax, Paul E ; Tebas, Pablo ; Tierney, Camlin ; Jahed, Nasreen C ; Myers, Laurie ; Melbourne, Kathleen ; Ha, Belinda ; Daar, Eric S2011 Jul 15Clin Infect Dis253
Peripheral and visceral fat changes following a treatment switch to a non-thymidine analogue or a nucleoside-sparing regimen in HIV-infected subjects with peripheral lipoatrophy: results of ACTG A5110.Tebas, P ; Zhang, J ; Hafner, R ; Tashima, K ; Shevitz, A ; Yarasheski, K ; Berzins, B ; Owens, S ; Forand, J ; Evans, S ; Murphy, R2009 MayJ Antimicrob Chemother563
Peripheral neuropathy in ART-experienced patients: prevalence and risk factors.Chen, Huichao ; Clifford, David B ; Deng, Lijuan ; Wu, Kunling ; Lee, Anthony J ; Bosch, Ronald J ; Riddler, Sharon A ; Ellis, Ronald J ; Evans, Scott R2013 DecJ Neurovirol619
Peripheral neuropathy in HIV: prevalence and risk factors.Evans, Scott R ; Ellis, Ronald J ; Chen, Huichao ; Yeh, Tzu-min ; Lee, Anthony J ; Schifitto, Giovanni ; Wu, Kunling ; Bosch, Ronald J ; McArthur, Justin C ; Simpson, David M ; Clifford, David B2011 Apr 24AIDS725
Persistence of nevirapine-resistant HIV-1 in women after single-dose nevirapine therapy for prevention of maternal-to-fetal HIV-1 transmission.Palmer, S ; Boltz, V ; Martinson, N ; Maldarelli, F ; Gray, G ; McIntyre, J ; Mellors, J ; Morris, L ; Coffin, J2006 May 2Proc Natl Acad Sci U S A18103
Persistently Elevated C-Reactive Protein Level in the First Year of Antiretroviral Therapy, Despite Virologic Suppression, Is Associated With HIV Disease Progression in Resource-Constrained Settings.Shivakoti, Rupak ; Yang, Wei-Teng ; Berendes, Sima ; Mwelase, Noluthando ; Kanyama, Cecilia ; Pillay, Sandy ; Samaneka, Wadzanai ; Santos, Breno ; Poongulali, Selvamuthu ; Tripathy, Srikanth ; Riviere, Cynthia ; Lama, Javier R ; Cardoso, Sandra W ; Sugandhavesa, Patcharaphan ; Balagopal, Ashwin ; Gupte, Nikhil ; Semba, Richard D ; Campbell2016 Apr 1J Infect Dis7213
Perturbations of circulating levels of RANKL-osteoprotegerin axis in relation to lipids and progression of atherosclerosis in HIV-infected and -uninfected adults: ACTG NWCS 332/A5078 Study.Kelesidis, Theodoros ; Kendall, Michelle A ; Yang, Otto O ; Hodis, Howard ; Currier, Judith S2013 JunAIDS Res Hum Retroviruses629
Pharmacodynamics of antiretroviral agents in HIV-1 infected patients: using viral dynamic models that incorporate drug susceptibility and adherence.Wu, Hulin ; Huang, Yangxin ; Acosta, Edward P ; Park, Jeong-Gun ; Yu, Song ; Rosenkranz, Susan L ; Kuritzkes, Daniel R ; Eron, Joseph J ; Perelson, Alan S ; Gerber, John G2006 AugJ Pharmacokinet Pharmacodyn433
Pharmacogenetics of nevirapine-associated hepatotoxicity: an Adult AIDS Clinical Trials Group collaboration.Haas, David W ; Bartlett, John A ; Andersen, Janet W ; Sanne, Ian ; Wilkinson, Grant R ; Hinkle, John ; Rousseau, Franck ; Ingram, Christiana D ; Shaw, Audrey ; Lederman, Michael M ; Kim, Richard B ; Adult AIDS Clinical Trials Group2006 Sep 15Clin Infect Dis643
Pharmacogenetics of plasma efavirenz exposure after treatment discontinuation: an Adult AIDS Clinical Trials Group Study.Ribaudo, Heather J ; Haas, David W ; Tierney, Camlin ; Kim, Richard B ; Wilkinson, Grant R ; Gulick, Roy M ; Clifford, David B ; Marzolini, Catia ; Fletcher, Courtney V ; Tashima, Karen T ; Kuritzkes, Daniel R ; Acosta, Edward P ; Adult AIDS Clinical Trials Group Study2006 Feb 1Clin Infect Dis342
Pharmacogenetics of unboosted atazanavir in HIV-infected individuals in resource-limited settings: a sub-study of the AIDS Clinical Trials Group (ACTG) PEARLS study (NWCS 342).Castillo-Mancilla, Jose R ; Aquilante, Christina L ; Wempe, Michael F ; Smeaton, Laura M ; Firnhaber, Cynthia ; LaRosa, Alberto M ; Kumarasamy, Nagalingeswaran ; Andrade, Adriana ; Baheti, Gautam ; Fletcher, Courtney V ; Campbell, Thomas B ; Haas, David W ; MaWhinney, Samantha ; Anderson, Peter L2016 JunJ Antimicrob Chemother671
Pharmacokinetic evaluation of the effects of ribavirin on zidovudine triphosphate formation: ACTG 5092s Study Team.Aweeka, F T ; Kang, M ; Yu, J-Y ; Lizak, P ; Alston, B ; Chung, R T ; AIDS Clinical Trials Group 5092s Study Team2007 JulHIV Med58
PHARMACOKINETIC EXPOSURE AND VIROLOGIC RESPONSE IN HIV-1 INFECTED PREGNANT WOMEN TREATED WITH LOPINAVIR/RITONAVIR: AIDS CLINICAL TRIALS GROUP PROTOCOL A5153S: A SUBSTUDY TO A5150.Sha, Beverly E ; Tierney, Camlin ; Sun, Xin ; Stek, Alice ; Cohn, Susan E ; Coombs, Robert W ; Bastow, Barbara ; Aweeka, Francesca T ; AIDS Clinical Trials Group (ACTG) 5153s Team2015Jacobs J AIDS HIV11
Pharmacokinetic interaction between efavirenz and dual protease inhibitors in healthy volunteers.Ma, Qing ; Forrest, Alan ; Rosenkranz, Susan L ; Para, Michael F ; Yarasheski, Kevin E ; Reichman, Richard C ; Morse, Gene D ; ACTG A5043 Protocol Team, DAIDS, NIH2008 MarBiopharm Drug Dispos229
Pharmacokinetic interaction between nelfinavir and pravastatin in HIV-seronegative volunteers: ACTG Study A5108.Aberg, Judith A ; Rosenkranz, Susan L ; Fichtenbaum, Carl J ; Alston, Beverly L ; Brobst, Susan W ; Segal, Yoninah ; Gerber, John G ; ACTG A5108 team2006 Mar 21AIDS520
Pharmacokinetic/pharmacodynamic modeling of the antiretroviral activity of the CCR5 antagonist Vicriviroc in treatment experienced HIV-infected subjects (ACTG protocol 5211).Crawford, Keith W ; Li, Chonghua ; Keung, Anther ; Su, Zhaohui ; Hughes, Michael D ; Greaves, Wayne ; Kuritzkes, Daniel ; Gulick, Roy ; Flexner, Charles ; ACTG A5211 Study Team2010 AprJ Acquir Immune Defic Syndr553
The pharmacokinetics and pharmacogenomics of efavirenz and lopinavir/ritonavir in HIV-infected persons requiring hemodialysis.Gupta, Samir K ; Rosenkranz, Susan L ; Cramer, Yoninah S ; Koletar, Susan L ; Szczech, Lynda A ; Amorosa, Valerianna ; Hall, Stephen D2008 Oct 1AIDS1522
The pharmacokinetics of lopinavir/ritonavir when given with isoniazid in South African HIV-infected individuals.Decloedt, E H ; van der Walt, J S ; McIlleron, H ; Wiesner, L ; Maartens, G2015 OctInt J Tuberc Lung Dis1019
Phase 2 study of the safety and efficacy of vicriviroc, a CCR5 inhibitor, in HIV-1-Infected, treatment-experienced patients: AIDS clinical trials group 5211.Gulick, Roy M ; Su, Zhaohui ; Flexner, Charles ; Hughes, Michael D ; Skolnik, Paul R ; Wilkin, Timothy J ; Gross, Robert ; Krambrink, Amy ; Coakley, Eoin ; Greaves, Wayne L ; Zolopa, Andrew ; Reichman, Richard ; Godfrey, Catherine ; Hirsch, Martin ; Kuritzkes, Daniel R ; AIDS Clinical Trials Group 5211 Team2007 Jul 15J Infect Dis2196
Phase 2 Study of the Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Men Who Have Sex With Men (HPTN 069/ACTG A5305).Gulick, Roy M ; Wilkin, Timothy J ; Chen, Ying Q ; Landovitz, Raphael J ; Amico, K Rivet ; Young, Alicia M ; Richardson, Paul ; Marzinke, Mark A ; Hendrix, Craig W ; Eshleman, Susan H ; McGowan, Ian ; Cottle, Leslie M ; Andrade, Adriana ; Marcus, Cheryl ; Klingman, Karin L ; Chege, Wairimu ; Rinehart, Alex R ; Rooney, James F ; Andrew, Phi2017 Jan 15J Infect Dis2215
Phase 3 trial of first generation protease inhibitor therapy for hepatitis C virus/human immunodeficiency virus coinfection.Sherman, Kenneth E ; Kang, Minhee ; Sterling, Richard ; Umbleja, Triin ; Marks, Kristen ; Kiser, Jennifer J ; Alston-Smith, Beverly ; Greaves, Wayne ; Butt, Adeel A2017 Feb 08World J Hepatol49
Phase I safety, pharmacokinetics, and pharmacogenetics study of the antituberculosis drug PA-824 with concomitant lopinavir-ritonavir, efavirenz, or rifampin.Dooley, Kelly E ; Luetkemeyer, Anne F ; Park, Jeong-Gun ; Allen, Reena ; Cramer, Yoninah ; Murray, Stephen ; Sutherland, Deborah ; Aweeka, Francesca ; Koletar, Susan L ; Marzan, Florence ; Bao, Jing ; Savic, Rada ; Haas, David W ; AIDS Clinical Trials Group A5306 Study Team2014 SepAntimicrob Agents Chemother958
Phase I/II trial of the anti-HIV activity of mifepristone in HIV-infected subjects ACTG 5200.Para, Michael F ; Schouten, Jeff ; Rosenkranz, Susan L ; Yu, Song ; Weiner, David ; Tebas, Pablo ; White, C Jo ; Reeds, Dominic ; Lertora, Juan ; Patterson, Kristine B ; Daar, Eric S ; Cavert, Winston ; Brizz, Barbara ; ACTG A5200 Team of the ACTG2010 Apr 1J Acquir Immune Defic Syndr453
Phenome-wide Association Study Relating Pretreatment Laboratory Parameters With Human Genetic Variants in AIDS Clinical Trials Group Protocols.Moore, Carrie B ; Verma, Anurag ; Pendergrass, Sarah ; Verma, Shefali S ; Johnson, Daniel H ; Daar, Eric S ; Gulick, Roy M ; Haubrich, Richard ; Robbins, Gregory K ; Ritchie, Marylyn D ; Haas, David W2015 JanOpen Forum Infect Dis12
PHENOME-WIDE INTERACTION STUDY (PheWIS) IN AIDS CLINICAL TRIALS GROUP DATA (ACTG).Verma, Shefali S ; Frase, Alex T ; Verma, Anurag ; Pendergrass, Sarah A ; Mahony, Shaun ; Haas, David W ; Ritchie, Marylyn D2016Pac Symp Biocomput21
Phenotype, Genotype, and Drug Resistance in Subtype C HIV-1 Infection.Derache, Anne ; Wallis, Carole L ; Vardhanabhuti, Saran ; Bartlett, John ; Kumarasamy, Nagalingeswaran ; Katzenstein, David2016 Jan 15J Infect Dis2213
Phylogenetic evidence of HIV-1 sequence evolution in subjects with persistent low-level viraemia.Vardhanabhuti, Saran ; Taiwo, Babafemi ; Kuritzkes, Daniel R ; Eron, Joseph J ; Bosch, Ronald J2015Antivir Ther120
Physicians' attitudes toward homosexuality and HIV: survey of a California Medical Society- revisited (PATHH-II).Smith, Davey M ; Mathews, Wm Christopher2007J Homosex3-452
A pilot study evaluating time to CD4 T-cell count <350 cells/mm(3) after treatment interruption following antiretroviral therapy +/- interleukin 2: results of ACTG A5102.Henry, Keith ; Katzenstein, David ; Cherng, Deborah Weng ; Valdez, Hernan ; Powderly, William ; Vargas, Michelle Blanchard ; Jahed, Nasreen C ; Jacobson, Jeffrey M ; Myers, Laurie S ; Schmitz, John L ; Winters, Mark ; Tebas, Pablo ; A5102 Study Team of the AIDS Clinical Trials Group2006 JunJ Acquir Immune Defic Syndr242
Pilot study of pioglitazone before HCV retreatment in HIV/HCV genotype 1-infected subjects with insulin resistance and previous nonresponse to peginterferon and ribavirin therapy: A5239.Marks, Kristen M ; Kitch, Douglas ; Chung, Raymond T ; Hadigan, Colleen ; Andersen, Janet ; Tien, Phyllis ; Luetkemeyer, Annie ; Alston-Smith, Beverly ; Glesby, Marshall J ; A5239 Team2014 Mar 1J Acquir Immune Defic Syndr365
A pilot study to determine the impact on dyslipidemia of adding tenofovir to stable background antiretroviral therapy: ACTG 5206.Tungsiripat, Marisa ; Kitch, Douglas ; Glesby, Marshall J ; Gupta, Samir K ; Mellors, John W ; Moran, Laura ; Jones, Lynne ; Alston-Smith, Beverly ; Rooney, James F ; Aberg, Judith A2010 Jul 17AIDS1124
A pilot trial of adding maraviroc to suppressive antiretroviral therapy for suboptimal CD4⁺ T-cell recovery despite sustained virologic suppression: ACTG A5256.Wilkin, Timothy J ; Lalama, Christina M ; McKinnon, John ; Gandhi, Rajesh T ; Lin, Nina ; Landay, Alan ; Ribaudo, Heather ; Fox, Lawrence ; Currier, Judith S ; Mellors, John W ; Gulick, Roy ; Tenorio, Allan R2012 Aug 15J Infect Dis4206
A placebo-controlled study of memantine for the treatment of human immunodeficiency virus-associated sensory neuropathy.Schifitto, Giovanni ; Yiannoutsos, Constantin T ; Simpson, David M ; Marra, Christina M ; Singer, Elyse J ; Kolson, Dennis L ; Nath, Avindra ; Berger, Joseph R ; Navia, Bradford ; Adult AIDS Clinical Trials Group (ACTG) 301 tEAM2006 AugJ Neurovirol412
Plasma apolipoprotein L1 levels do not correlate with CKD.Bruggeman, Leslie A ; O'Toole, John F ; Ross, Michael D ; Madhavan, Sethu M ; Smurzynski, Marlene ; Wu, Kunling ; Bosch, Ronald J ; Gupta, Samir ; Pollak, Martin R ; Sedor, John R ; Kalayjian, Robert C2014 MarJ Am Soc Nephrol325
Plasma Efavirenz Concentrations Are Associated With Lipid and Glucose Concentrations.Sinxadi, Phumla Zuleika ; McIlleron, Helen Margaret ; Dave, Joel Alex ; Smith, Peter John ; Levitt, Naomi Sharlene ; Haas, David William ; Maartens, Gary2016 JanMedicine (Baltimore)295
Plasma HIV-1 RNA dynamics in antiretroviral-naive subjects receiving either triple-nucleoside or efavirenz-containing regimens: ACTG A5166s.Kuritzkes, Daniel R ; Ribaudo, Heather J ; Squires, Kathleen E ; Koletar, Susan L ; Santana, Jorge ; Riddler, Sharon A ; Reichman, Richard ; Shikuma, Cecilia ; Meyer, William A ; Klingman, Karin L ; Gulick, Roy M ; ACTG A5166s Protocol Team2007 Apr 15J Infect Dis8195
Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection.Jiang, Wei ; Lederman, Michael M ; Hunt, Peter ; Sieg, Scott F ; Haley, Kathryn ; Rodriguez, Benigno ; Landay, Alan ; Martin, Jeffrey ; Sinclair, Elizabeth ; Asher, Ava I ; Deeks, Steven G ; Douek, Daniel C ; Brenchley, Jason M2009 Apr 15J Infect Dis8199
Poly(lactic-co-glycolic) Acid-Chitosan Dual Loaded Nanoparticles for Antiretroviral Nanoformulations.Makita-Chingombe, Faithful ; Kutscher, Hilliard L ; DiTursi, Sara L ; Morse, Gene D ; Maponga, Charles C2016J Drug Deliv2016
Population pharmacokinetic drug-drug interaction pooled analysis of existing data for rifabutin and HIV PIs.Hennig, Stefanie ; Svensson, Elin M ; Niebecker, Ronald ; Fourie, P Bernard ; Weiner, Marc H ; Bonora, Stefano ; Peloquin, Charles A ; Gallicano, Keith ; Flexner, Charles ; Pym, Alex ; Vis, Peter ; Olliaro, Piero L ; McIlleron, Helen ; Karlsson, Mats O2016 MayJ Antimicrob Chemother571
Postpartum viral load rebound in HIV-1-infected women treated with highly active antiretroviral therapy: AIDS Clinical Trials Group Protocol A5150.Sha, Beverly E ; Tierney, Camlin ; Cohn, Susan E ; Sun, Xin ; Coombs, Robert W ; Frenkel, Lisa M ; Kalams, Spyros A ; Aweeka, Francesca T ; Bastow, Barbara ; Bardeguez, Arlene ; Kmack, Anne ; Stek, Alice ; Aids Clinical Trials Group ACTG A5150 Team2011 Jan-FebHIV Clin Trials112
Potential impact of antiretroviral therapy on HIV-1 transmission and AIDS mortality in resource-limited settings.Abbas, Ume L ; Anderson, Roy M ; Mellors, John W2006 Apr 15J Acquir Immune Defic Syndr541
Potential risks and benefits of HIV treatment simplification: a simulation model of a proposed clinical trial.Schackman, Bruce R ; Scott, Callie A ; Sax, Paul E ; Losina, Elena ; Wilkin, Timothy J ; McKinnon, John E ; Swindells, Susan ; Weinstein, Milton C ; Freedberg, Kenneth A2007 Oct 15Clin Infect Dis845
Pre-antiretroviral therapy serum selenium concentrations predict WHO stages 3, 4 or death but not virologic failure post-antiretroviral therapy.Shivakoti, Rupak ; Gupte, Nikhil ; Yang, Wei-Teng ; Mwelase, Noluthando ; Kanyama, Cecilia ; Tang, Alice M ; Pillay, Sandy ; Samaneka, Wadzanai ; Riviere, Cynthia ; Berendes, Sima ; Lama, Javier R ; Cardoso, Sandra W ; Sugandhavesa, Patcharaphan ; Semba, Richard D ; Christian, Parul ; Campbell, Thomas B ; Gupta, Amita ; NWCS 319 and PEARLS2014 NovNutrients116
Pre-cART Elevation of CRP and CD4+ T-Cell Immune Activation Associated With HIV Clinical Progression in a Multinational Case-Cohort Study.Balagopal, Ashwin ; Asmuth, David M ; Yang, Wei-Teng ; Campbell, Thomas B ; Gupte, Nikhil ; Smeaton, Laura ; Kanyama, Cecilia ; Grinsztejn, Beatriz ; Santos, Breno ; Supparatpinyo, Khuanchai ; Badal-Faesen, Sharlaa ; Lama, Javier R ; Lalloo, Umesh G ; Zulu, Fatima ; Pawar, Jyoti S ; Riviere, Cynthia ; Kumarasamy, Nagalingeswaran ; Hakim, J2015 Oct 1J Acquir Immune Defic Syndr270
Predicting resistance as indicator for need to switch from first-line antiretroviral therapy among patients with elevated viral loads: development of a risk score algorithm.Rutstein, Sarah E ; Hosseinipour, Mina C ; Weinberger, Morris ; Wheeler, Stephanie B ; Biddle, Andrea K ; Wallis, Carole L ; Balakrishnan, Pachamuthu ; Mellors, John W ; Morgado, Mariza ; Saravanan, Shanmugam ; Tripathy, Srikanth ; Vardhanabhuti, Saran ; Eron, Joseph J ; Miller, William C2016BMC Infect Dis116
Predictive value of pharmacokinetics-adjusted phenotypic susceptibility on response to ritonavir-enhanced protease inhibitors (PIs) in human immunodeficiency virus-infected subjects failing prior PI therapy.Eron, Joseph J ; Park, Jeong-Gun ; Haubrich, Richard ; Aweeka, Francesca ; Bastow, Barbara ; Pakes, Gary E ; Yu, Song ; Wu, Hulin ; Richman, Douglas D ; ACTG5126 Study Team2009 JunAntimicrob Agents Chemother653
Predictors and outcomes of Mycobacterium tuberculosis bacteremia among patients with HIV and tuberculosis co-infection enrolled in the ACTG A5221 STRIDE study.Crump, John A ; Wu, Xingye ; Kendall, Michelle A ; Ive, Prudence D ; Kumwenda, Johnstone J ; Grinsztejn, Beatriz ; Jentsch, Ute ; Swindells, Susan2015BMC Infect Dis15
Predictors of AIDS-related morbidity and mortality in a southern U.S. Cohort.Mugavero, Michael J ; Pence, Brian Wells ; Whetten, Kathryn ; Leserman, Jane ; Swartz, Marvin ; Stangl, Dalene ; Thielman, Nathan M2007 SepAIDS Patient Care STDS921
Predictors of antiretroviral-related hepatotoxicity in the adult AIDS Clinical Trial Group (1989-1999).Servoss, Julie C ; Kitch, Douglas W ; Andersen, Janet W ; Reisler, Ronald B ; Chung, Raymond T ; Robbins, Gregory K2006 Nov 1J Acquir Immune Defic Syndr343
Predictors of late virologic failure after initial successful suppression of HIV replication on efavirenz-based antiretroviral therapy.Singini, Isaac ; Campbell, Thomas B ; Smeaton, Laura M ; Kumarasamy, Nagalingeswaran ; La Rosa, Alberto ; Taejareonkul, Sineenart ; Safren, Steven A ; Flanigan, Timothy P ; Hakim, James G ; Hughes, Michael D ; ACTG A5175/PEARLS Study Team.2016 Jul 29HIV Clin Trials
Predictors of residual viraemia in patients on long-term suppressive antiretroviral therapy.Zheng, Lu ; Bosch, Ronald J ; Chan, Ellen S ; Read, Sarah ; Kearney, Mary ; Margolis, David M ; Mellors, John W ; Eron, Joseph J ; Gandhi, Rajesh T ; DS Clinical Trials Group (ACTG) A5244 Team2013Antivir Ther118
Predictors of suboptimal CD4 response among women achieving virologic suppression in a randomized antiretroviral treatment trial, Africa.Asmelash, Aida ; Zheng, Yu ; Kaloustian, Kara Wools ; Shaffer, Douglas ; Sawe, Fred ; Ogwu, Anthony ; Salata, Robert ; Currier, Judith ; Hughes, Michael D ; Lockman, Shahin2014BMC Infect Dis14
Pre-existing minority drug-resistant HIV-1 variants, adherence, and risk of antiretroviral treatment failure.Paredes, Roger ; Lalama, Christina M ; Ribaudo, Heather J ; Schackman, Bruce R ; Shikuma, Cecilia ; Giguel, Francoise ; Meyer, William A ; Johnson, Victoria A ; Fiscus, Susan A ; D'Aquila, Richard T ; Gulick, Roy M ; Kuritzkes, Daniel R ; AIDS Clinical Trials Group (ACTG) A5095 Study Team2010 MarJ Infect Dis5201
Preexisting resistance to nonnucleoside reverse-transcriptase inhibitors predicts virologic failure of an efavirenz-based regimen in treatment-naive HIV-1-infected subjects.Kuritzkes, Daniel R ; Lalama, Christina M ; Ribaudo, Heather J ; Marcial, Michelle ; Meyer, William A ; Shikuma, Cecilia ; Johnson, Victoria A ; Fiscus, Susan A ; D'Aquila, Richard T ; Schackman, Bruce R ; Acosta, Edward P ; Gulick, Roy M2008 Mar 15J Infect Dis6197
Presence of Plasmodium falciparum DNA in Plasma Does Not Predict Clinical Malaria in an HIV-1 Infected Population.Orlov, Marika ; Smeaton, Laura M ; Kumwenda, Johnstone ; Hosseinipour, Mina C ; Campbell, Thomas B ; Schooley, Robert T2015PLoS One610
Pretreatment factors associated with 3-year (144-week) virologic and immunologic responses to potent antiretroviral therapy.Bosch, Ronald J ; Bennett, Kara ; Collier, Ann C ; Zackin, Robert ; Benson, Constance A2007 Mar 1J Acquir Immune Defic Syndr344
Pretreatment HIV Drug Resistance and HIV-1 Subtype C Are Independently Associated With Virologic Failure: Results From the Multinational PEARLS (ACTG A5175) Clinical Trial.Kantor, Rami ; Smeaton, Laura ; Vardhanabhuti, Saran ; Hudelson, Sarah E ; Wallis, Carol L ; Tripathy, Srikanth ; Morgado, Mariza G ; Saravanan, Shanmugham ; Balakrishnan, Pachamuthu ; Reitsma, Marissa ; Hart, Stephen ; Mellors, John W ; Halvas, Elias ; Grinsztejn, Beatriz ; Hosseinipour, Mina C ; Kumwenda, Johnstone ; La Rosa, Alberto ; L2015 May 15Clin Infect Dis1060
Pretreatment levels of soluble cellular receptors and interleukin-6 are associated with HIV disease progression in subjects treated with highly active antiretroviral therapy.Kalayjian, Robert C ; Machekano, Rhoderick N ; Rizk, Nesrine ; Robbins, Gregory K ; Gandhi, Rajesh T ; Rodriguez, Benigno A ; Pollard, Richard B ; Lederman, Michael M ; Landay, Alan2010 Jun 15J Infect Dis12201
The prevalence and incidence of neurocognitive impairment in the HAART era.Robertson, Kevin R ; Smurzynski, Marlene ; Parsons, Thomas D ; Wu, Kunling ; Bosch, Ronald J ; Wu, Julia ; McArthur, Justin C ; Collier, Ann C ; Evans, Scott R ; Ellis, Ron J2007 Sep 12AIDS1421
Prevalence and persistence of cervical human papillomavirus infection in HIV-positive women initiating highly active antiretroviral therapy.Fife, Kenneth H ; Wu, Julia W ; Squires, Kathleen E ; Watts, D Heather ; Andersen, Janet W ; Brown, Darron R2009 Jul 1J Acquir Immune Defic Syndr351
Prevalence and risk factors of micronutrient deficiencies pre- and post-antiretroviral therapy (ART) among a diverse multicountry cohort of HIV-infected adults.Shivakoti, Rupak ; Christian, Parul ; Yang, Wei-Teng ; Gupte, Nikhil ; Mwelase, Noluthando ; Kanyama, Cecilia ; Pillay, Sandy ; Samaneka, Wadzanai ; Santos, Breno ; Poongulali, Selvamuthu ; Tripathy, Srikanth ; Riviere, Cynthia ; Berendes, Sima ; Lama, Javier R ; Cardoso, Sandra W ; Sugandhavesa, Patcharaphan ; Tang, Alice M ; Semba, Richa2016 FebClin Nutr135
Prevalence of primary resistance at baseline in acutely and recently infected subjects enrolled in AIDS clinical trials group protocol 371.Dykes, Carrie ; Mukherjee, A Lisa ; Bosch, Ronald J ; Connick, Elizabeth ; Volberding, Paul A ; Demeter, Lisa M2010 SepJ Acquir Immune Defic Syndr155
Prevention of HIV-1 infection with early antiretroviral therapy.Cohen, Myron S ; Chen, Ying Q ; McCauley, Marybeth ; Gamble, Theresa ; Hosseinipour, Mina C ; Kumarasamy, Nagalingeswaran ; Hakim, James G ; Kumwenda, Johnstone ; Grinsztejn, Beatriz ; Pilotto, Jose H S ; Godbole, Sheela V ; Mehendale, Sanjay ; Chariyalertsak, Suwat ; Santos, Breno R ; Mayer, Kenneth H ; Hoffman, Irving F ; Eshleman, Susan2011 Aug 11N Engl J Med6365
Prior illicit drug use and missed prenatal vitamins predict nonadherence to antiretroviral therapy in pregnancy: adherence analysis A5084.Cohn, Susan E ; Umbleja, Triin ; Mrus, Joseph ; Bardeguez, Arlene D ; Andersen, Janet W ; Chesney, Margaret A2008 JanAIDS Patient Care STDS122
Progression of carotid artery intima-media thickening in HIV-infected and uninfected adults.Currier, Judith S ; Kendall, Michelle A ; Henry, W Keith ; Alston-Smith, Beverly ; Torriani, Francesca J ; Tebas, Pablo ; Li, Yanjie ; Hodis, Howard N2007 May 31AIDS921
A prospective, randomized clinical trial of antiretroviral therapies on carotid wall thickness.Stein, James H ; Ribaudo, Heather J ; Hodis, Howard N ; Brown, Todd T ; Tran, Thuy Tien T ; Yan, Mingzhu ; Brodell, Elizabeth Lauer ; Kelesidis, Theodore ; McComsey, Grace A ; Dubé, Michael P ; Murphy, Robert L ; Currier, Judith S2015 Sep 10AIDS1429
Protease Inhibitor Resistance Is Uncommon in HIV-1 Subtype C Infected Patients on Failing Second-Line Lopinavir/r-Containing Antiretroviral Therapy in South Africa.Wallis, Carole L ; Mellors, John W ; Venter, Willem D F ; Sanne, Ian ; Stevens, Wendy2011AIDS Res Treat2011
Protease inhibitor-based antiretroviral therapy and glucose tolerance in pregnancy: AIDS Clinical Trials Group A5084.Hitti, Jane ; Andersen, Janet ; McComsey, Grace ; Liu, Tun ; Melvin, Ann ; Smith, Laura ; Stek, Alice ; Aberg, Judith ; Hull, Andrew ; Alston-Smith, Beverly ; Watts, D Heather ; Livingston, Elizabeth ; AIDS Clinical Trials Group 5084 Study Team2007 AprAm J Obstet Gynecol4196
Proteinuria, creatinine clearance, and immune activation in antiretroviral-naive HIV-infected subjects.Gupta, Samir K ; Komarow, Lauren ; Gulick, Roy M ; Pollard, Richard B ; Robbins, Gregory K ; Franceschini, Nora ; Szczech, Lynda A ; Koletar, Susan L ; Kalayjian, Robert C2009 Aug 15J Infect Dis4200
Proteinuria is associated with neurocognitive impairment in antiretroviral therapy treated HIV-infected individuals.Kalayjian, Robert C ; Wu, Kunling ; Evans, Scott ; Clifford, David B ; Pallaki, Muraldihar ; Currier, Judith S ; Smryzynski, Marlene2014 Sep 1J Acquir Immune Defic Syndr167
Proton MRS and neuropsychological correlates in AIDS dementia complex: evidence of subcortical specificity.Paul, Robert H ; Yiannoutsos, Constantin T ; Miller, Eric N ; Chang, Linda ; Marra, Christina M ; Schifitto, Giovanni ; Ernst, Thomas ; Singer, Elyse ; Richards, Todd ; Jarvik, G Jeffrey ; Price, Richard ; Meyerhoff, Dieter J ; Kolson, Dennis ; Ellis, Ronald J ; Gonzalez, Gilberto ; Lenkinski, Robert E ; Cohen, Ronald A ; Navia, Bradford A2007 SummerJ Neuropsychiatry Clin Neurosci319
Psychosocial predictors of non-adherence and treatment failure in a large scale multi-national trial of antiretroviral therapy for HIV: data from the ACTG A5175/PEARLS trial.Safren, Steven A ; Biello, Katie B ; Smeaton, Laura ; Mimiaga, Matthew J ; Walawander, Ann ; Lama, Javier R ; Rana, Aadia ; Nyirenda, Mulinda ; Kayoyo, Virginia M ; Samaneka, Wadzanai ; Joglekar, Anjali ; Celentano, David ; Martinez, Ana ; Remmert, Jocelyn E ; Nair, Aspara ; Lalloo, Umesh G ; Kumarasamy, Nagalingeswaran ; Hakim, James ; Ca2014PLoS One89